Global Polymerase Chain Reaction (PCR) Devices Market Size Study, By Technology (Digital PCR, Real-time PCR), By Product Type (Instrument, Reagent, Consumables, Others), By Application (Oncology, Blood Testing, Pathogen Detection, Research, Forensic, Othe

Global Polymerase Chain Reaction (PCR) Devices Market Size Study, By Technology (Digital PCR, Real-time PCR), By Product Type (Instrument, Reagent, Consumables, Others), By Application (Oncology, Blood Testing, Pathogen Detection, Research, Forensic, Others), By End-User (Hospital, Diagnostic Center, Pharmaceutical and Biotechnology Companies, Clinical Research Organizations, Academia, Laboratories), and Regional Forecasts 2022–2032


The Global Polymerase Chain Reaction (PCR) Devices Market was valued at approximately USD 13.65 billion in 2023 and is projected to grow at a modest CAGR of 7.0% over the forecast period of 2024–2032. PCR devices, commonly referred to as thermal cyclers, play a critical role in amplifying DNA sequences, supporting their broad application across diverse fields such as clinical diagnostics, oncology, and microbiological research. This growth is further driven by the rising adoption of personalized medicine and precision diagnostics.

Increased utilization in clinical diagnostics and advancements in PCR technologies are fueling market expansion. PCR devices are instrumental in detecting genetic disorders and infectious diseases, ensuring precise diagnosis and treatment. Moreover, the growing reliance on biomarkers for disease diagnosis and the increasing demand for point-of-care diagnostic devices are shaping the market trajectory. Key innovations in real-time and digital PCR technologies have expanded their applications, driving adoption in forensics, pathogen detection, and oncology.

North America currently dominates the market, attributed to favorable government initiatives and established healthcare infrastructure. Meanwhile, the Asia-Pacific region is poised for substantial growth during the forecast period, driven by heightened awareness of early diagnostics and increasing investments in healthcare technologies. Emerging markets in China, India, and Southeast Asia present lucrative opportunities due to their growing patient pool and rising prevalence of chronic diseases.

Major market players included in this report are:
• Abbott
• Thermo Fisher Scientific
• BD (Becton, Dickinson and Company)
• bioMérieux
• Danaher
• QIAGEN
• Bio-Rad Laboratories, Inc.
• Siemens Healthineers
• Merck KGaA
• Fluidigm Corporation
• Agilent Technologies, Inc.
• Cytiva
• Stryker Corporation
• Smith+Nephew
• Bruker Corporation

The detailed segments and sub-segments of the market are explained below:

By Technology
• Digital PCR
• Real-time PCR

By Product Type
• Instrument
• Reagent
• Consumables
• Others

By Application
• Oncology
• Blood Testing
• Pathogen Detection
• Research
• Forensic
• Others

By End User
• Hospital
• Diagnostic Center
• Pharmaceutical and Biotechnology Companies
• Clinical Research Organizations
• Academia
• Laboratories

________________________________________

By Region:
• North America
U.S.
Canada
Mexico
• Europe
Germany
France
U.K.
Italy
Spain
Turkey
Rest of Europe
• Asia Pacific
China
Japan
India
South Korea
Singapore
Australia
Thailand
Indonesia
Rest of Asia Pacific
• Middle East & Africa
Saudi Arabia
UAE
South Africa
Rest of MEA
• Latin America
Brazil
Argentina
Rest of Latin America

________________________________________

Years considered for the study are as follows:
• Historical year – 2022
• Base year – 2023
• Forecast period – 2024 to 2032

Key Takeaways
• Market Estimates & Forecast for 10 years from 2022 to 2032
• Annualized revenues and regional-level analysis for each market segment
• Detailed analysis of geographical landscape with country-level insights
• Competitive landscape with information on key players and strategies
• Analysis of key business strategies and recommendations for market entry
• Demand-side and supply-side dynamics analysis of the market

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.


Chapter 1: Global Polymerase Chain Reaction (PCR) Devices Market Executive Summary
1.1. Global PCR Devices Market Size & Forecast (2022–2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Technology
1.3.2. By Product Type
1.3.3. By Application
1.3.4. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2: Global Polymerase Chain Reaction (PCR) Devices Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply-Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand-Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3: Global Polymerase Chain Reaction (PCR) Devices Market Dynamics
3.1. Market Drivers
3.1.1. Adoption of Personalized Medicine
3.1.2. Increased Demand for Precision Diagnostics
3.1.3. Technological Advancements in PCR Devices
3.2. Market Challenges
3.2.1. High Costs of Advanced PCR Devices
3.2.2. Limited Awareness in Emerging Markets
3.3. Market Opportunities
3.3.1. Expanding Applications in Forensics and Oncology
3.3.2. Investment in Research and Development Activities
Chapter 4: Global Polymerase Chain Reaction (PCR) Devices Market Industry Analysis
4.1. Porter’s Five Forces Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Future Approach to Porter’s Five Forces Model
4.1.7. Porter’s Five Forces Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Disruptive Trends
4.5. Analyst Recommendations
Chapter 5: Global Polymerase Chain Reaction (PCR) Devices Market Size & Forecast by Technology (2022–2032)
5.1. Segment Dashboard
5.2. Market Revenue by Technology, 2022 & 2032 (USD Billion)
5.2.1. Digital PCR
5.2.2. Real-time PCR
Chapter 6: Global Polymerase Chain Reaction (PCR) Devices Market Size & Forecast by Product Type (2022–2032)
6.1. Segment Dashboard
6.2. Market Revenue by Product Type, 2022 & 2032 (USD Billion)
6.2.1. Instrument
6.2.2. Reagent
6.2.3. Consumables
6.2.4. Others
Chapter 7: Global Polymerase Chain Reaction (PCR) Devices Market Size & Forecast by Application (2022–2032)
7.1. Segment Dashboard
7.2. Market Revenue by Application, 2022 & 2032 (USD Billion)
7.2.1. Oncology
7.2.2. Blood Testing
7.2.3. Pathogen Detection
7.2.4. Research
7.2.5. Forensic
7.2.6. Others
Chapter 8: Global Polymerase Chain Reaction (PCR) Devices Market Size & Forecast by End User (2022–2032)
8.1. Segment Dashboard
8.2. Market Revenue by End User, 2022 & 2032 (USD Billion)
8.2.1. Hospital
8.2.2. Diagnostic Center
8.2.3. Pharmaceutical and Biotechnology Companies
8.2.4. Clinical Research Organizations
8.2.5. Academia
8.2.6. Laboratories
Chapter 9: Global Polymerase Chain Reaction (PCR) Devices Market Size & Forecast by Region (2022–2032)
9.1. North America PCR Devices Market
9.1.1. U.S. Market
9.1.2. Canada Market
9.2. Europe PCR Devices Market
9.2.1. Germany Market
9.2.2. U.K. Market
9.2.3. France Market
9.2.4. Italy Market
9.2.5. Spain Market
9.2.6. Rest of Europe
9.3. Asia-Pacific PCR Devices Market
9.3.1. China Market
9.3.2. Japan Market
9.3.3. India Market
9.3.4. South Korea Market
9.3.5. Australia Market
9.3.6. Rest of Asia-Pacific
9.4. Latin America PCR Devices Market
9.4.1. Brazil Market
9.4.2. Argentina Market
9.4.3. Rest of Latin America
9.5. Middle East & Africa PCR Devices Market
9.5.1. Saudi Arabia Market
9.5.2. UAE Market
9.5.3. South Africa Market
9.5.4. Rest of MEA
Chapter 10: Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Abbott
10.1.2. Thermo Fisher Scientific
10.1.3. Danaher
10.2. Competitive Landscape
10.3. Market Strategies
10.4. Company Profiles
10.4.1. bioMérieux
10.4.2. Bio-Rad Laboratories
10.4.3. QIAGEN
Chapter 11: Research Process
11.1. Research Methodology
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
List of Tables
1. Global Market by Technology, 2022–2032 (USD Billion)
2. Market Revenue by Product Type, 2022–2032 (USD Billion)
3. Market Revenue by Application, 2022–2032 (USD Billion)
4. Market Revenue by Region, 2022–2032 (USD Billion)
5. Key Industry Trends and Growth Drivers
6. SWOT Analysis of Major Market Players
7. Competitive Positioning Analysis
This list is not complete. Final report contains over 100 tables.
List of Figures
1. Global PCR Devices Market Revenue by Region, 2022 & 2032 (USD Billion)
2. Market Share by Technology, 2022 & 2032
3. Regional Analysis of Revenue Growth, 2022–2032
4. Competitive Landscape Heatmap, 2023
5. Growth Opportunities by Application Segment, 2022–2032
6. Key Technological Innovations in PCR Devices
This list is not complete. Final report contains over 50 figures.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings